연구동향 분석
박사

말라리아 예방화학요법과 조기진단에 관한 비용-편익분석 : 말라리아 위험지역에 근무하는 군인을 대상으로

김희성 2016년

논문상세정보
인용/피인용
' 말라리아 예방화학요법과 조기진단에 관한 비용-편익분석 : 말라리아 위험지역에 근무하는 군인을 대상으로' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 510.75
  • Rapid diagnostic test kit
  • chemoprophylaxis
  • cost-benefit analysis
  • malaria
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
69 0

0.0%

' 말라리아 예방화학요법과 조기진단에 관한 비용-편익분석 : 말라리아 위험지역에 근무하는 군인을 대상으로' 의 참고문헌

  • 한국형 말라리아의 수학모형과 응용프로그램 개발
    김용국 질 병관리본부, 오송 [2008]
  • 한국적 상황을 고려한 비교효과연구 방법론
  • 질병관리본부, 말라리아 위험지역의 말라리아 항체양성률 평가연구, 오송
    질병관리본부 [2013]
  • 질병관리본부, 2015 국내 말라리아 관리지침, 오송
    질병관리본부 [2015]
  • 보건경제학
    양봉민 나남, 서울 [2006]
  • “전방사단의 말라리 아 예방약에 대한 비용-효과 분석,”
    강성욱 권근상 박순정 백승곤 정창식 황대환 대한군진의학학술지, 33(1), 45-54 [2002]
  • World Health Organizatioon(2015), World malaria report 2015, Geneva, Switzerland, World Health Organization.
  • World Health Organization(n.d.), "Determining Cost Effectiveness of Malaria Rapid Diagnostic Tests in Rural Areas with High Prevalence," Retrieved from http://www.wpro.who.int/malaria/NR/rdonlyres/0A45DF24-4245-4BF3-96E7-5F1 150AF333B/0/DeterminingCostEffectivenessofRDTsinruralareaswithhighprevalen ce.pdf.
  • World Health Organization(2015), Global technical strategy for malaria 2016-2030, Geneva, Switzerland, World Health Organization.
  • World Health Organization(2012), WHO policy recommendation: seosonal malaria chemoprevention(SMC) for plasmodium falciparum malaria control in highly seosonal transmission areas of the Sahel sub-region in Africa, Geneva, Switzerland, World Health Organization.
  • World Health Organization(2010), Mathematical modelling to support malaria control and elimination, Geneva, Switzerland, World Health Organization.
  • World Health Organization(2000), Malaria diagnosis new perspectives. Report of a joint WHO/USAID informal consultation, Geneva, Switzerland, World Health Organization.
  • Wongsrichanalai C., M. J. Barcus, S. Muth, A. Sutamihardja, W. H. Wernsdorfer(2007), "A review of malaria diagnostic tools: microscopy and rapid diagnostic test (RDT)," Am J Trop Med Hyg. 77(6), 119-127.
  • Widmer L. L., P. R. Blank, K. Van Herck, C. Hatz, P. Schlagenhauf(2010), “Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa,” BMC Infect Dis. 10, 279.
  • Vivona S., G. J. Brewer, M. Conrad, A. S. Alving(1961), "The concurrent weekly administration of chloroquine and primaquine for the prevention of Korean vivax malaria," Bull World Health Organ, 25, 267-269.
  • Thiam S., M. Thior, B. Faye, M. Ndiop, M. L. Diouf, M. B. Diouf, I. Diallo, F. B. Fall, J. L. Ndiaye, A. Albertini, E. Lee, P. Jorgensen, O. Gaye, D. Bell(2011), "Major reduction in anti-malarial drug consumption in Senegal after nation-wide introduction of malaria rapid diagnostic tests," PLoS One. 6(4), e18419.
  • Tediosi F., N. Maire, T. Smith, G. Hutton, J. Utzinger, A. Ross, M, Tanner(2006), "An approach to model the costs and effects of case management of Plasmodium falciparum malaria in sub-saharan Africa," Am J Trop Med Hyg. 75(2), 90-103.
  • Smith D. L., F. E. McKenzie(2004), "Statics and dynamics of malaria infection in Anopheles mosquitoes," Malar J. 3, 13.
  • Shillcutt S., C. Morel, C. Goodman, P. Coleman, D. Bell, C. J. Whitty, A. Mills(2008), “Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy,” Bull World Health Organ. 86(2), 101-110.
  • Saha S., T. J. Hoerger, M. P. Pignone, S. M. Teutsch, M. Helfand, J. S. Mandelblatt(2001), “Cost Work Group, Third US Preventive Services Task Force. The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services,” Am J Prev Med. 20(3), 36-43.
  • Price R. N., E. Tjitra, C. A. Guerra, S. Yeung, N. J. White, N. M. Anstey(2007), “Vivax malaria: neglected and not benign,” Am J Trop Med Hyg. 77(6), 79-87.
  • Park, J. W., G. Jun, J. S. Yeom(2009), "Plasmodium vivax malaria: status in the Republic of Korea following reemergence," Korean J Parasitol, 47, S39-50.
  • Park K., J. K. Kang(2003), "Effectiveness of primaquine terminal prophylaxis against late primary attacks of Plasmodium vivax malaria: a case-control study among troops of the Republic of Korea army," Trans R Soc Trop Med Hyg. 97(4), 441-442.
  • Ockenhouse C. F., A. Magill, D. Smith, W. Milhous(2005), "History of U.S. military contributions to the study of malaria," Mil Med. 170(4), 12-16.
  • Mueller I., M. R. Galinski, J. K. Baird, J. M. Carlton, D. K. Kochar, P. L. Alonso, H. A. del Portillo(2009), “Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite,” Lancet Infect Dis. 9(9), 555-566.
  • Moody A. H., P. L. Chiodini(2002), "Non-microscopic method for malaria diagnosis using OptiMAL IT, a second-generation dipstick for malaria pLDH antigen detection," Br J Biomed Sci. 59(4), 228-231.
  • McKenzie F. E., G. M. Jeffery, W. E. Collins(2007), "Gametocytemia and fever in human malaria infections," J Parasitol. 93(3), 627-633.
  • Maude R. J., W. Pontavornpinyo, S. Saralamba, A. M. Dondorp, N. P. Day, N. J. White, L. J. White(2009), "The role of mathematical modelling in malaria elimination and eradication (Comment on: Can malaria be eliminated?)," Trans R Soc Trop Med Hyg. 103(6), 643-644.
  • Massad E., B. C. Behrens, F. A. Coutinho, R. H. Behrens(2011), “Cost risk benefit analysis to support chemoprophylaxis policy for travellers to malaria endemic countries,” Malar J. 10, 130.
  • Lubell Y., H. Reyburn, H. Mbakilwa, R. Mwangi, S. Chonya, C. J. Whitty, A. Mills(2008), “The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis,” BMJ. 336(7637), 202-205.
  • Lee H. J., J. H. Baek, M. H. Chae, H. Joo, J. S. Lee, M. H. Chung, Y. K. Park, J. T. Kim(2013), "A case of vivax malaria complicated by adult respiratory distress syndrome and successful management with extracorporeal membrane oxygenation," Korean J Parasitol. 51(5), 551-555.
  • Kondrashin A., A. M. Baranova, E. A. Ashley, J. Recht, N. J. White, V. P. Sergiev(2014), "Mass primaquine treatment to eliminate vivax malaria: lessons from the past," Malar J. 13, 51.
  • Kim J. Y., S. Y. Ji, Y. K. Goo, B. K. Na, H. J. Pyo, H. N. Lee, J. Lee , N. H. Kim, L. von Seidlein, Q. Cheng, S. H. Cho, W. J. Lee(2013), "Comparison of rapid diagnostic tests for the detection of Plasmodium vivax malaria in South Korea," PLoS One. 8(5), e64353.
  • Kho W. G., J. Y. Jang, S. T. Hong, H. W. Lee, W. J. Lee, J. S. Lee(1999), "Border malaria characters of reemerging vivax malaria in the Republic of Korea," Korean J Parasitol. 37(2), 71-76.
  • Hay S. I., C. A. Guerra, A. J. Tatem, A. M. Noor, R. W. Snow(2004), “The global distribution and population at risk of malaria: past, present, and future,” Lancet Infect Dis, 4(6), 327-336.
  • Hansen K. S., E. Grieve, A. Mikhail, I. Mayan, N. Mohammed, M. Anwar, S. H. Baktash, T. L. Drake, C. J. Whitty, M. W. Rowland, T. J. Leslie(2015), "Cost-effectiveness of malaria diagnosis using rapid diagnostic tests compared to microscopy or clinical symptoms alone in Afghanistan," Malar J. 14, 217.
  • Guerra C. A., R. W. Snow, S. I. Hay(2006), "Mapping the global extent of malaria in 2005," Trends Parasitol, 22(8), 353-358.
  • Greenwood B.(2010), "Anti-malarial drugs and the prevention of malaria in the population of malaria endemic areas," Malar J. 9(3), S2.
  • Greenwood B.(2004), "The use of anti-malarial drugs to prevent malaria in the population of malaria-endemic areas," Am J Trop Med Hyg, 70(1), 1-7.
  • Greenwood B. M., P. H. David, L. N. Otoo-Forbes, S. J. Allen, P. L. Alonso, J. R. Armstrong Schellenberg, P. Byass, M. Hurwitz, A. Menon , R. W. Snow(1995), "Mortality and morbidity from malaria after stopping malaria chemoprophylaxis." Trans R Soc Trop Med Hyg. 89(6), 629-633.
  • Goo Y. K., S. Y. Ji, H. I. Shin, J. H. Moon, S. H. Cho, W. J. Lee, J. Y. Kim(2014), "First evaluation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in vivax malaria endemic regions in the Republic of Korea," PLoS One. 9(5), e97390.
  • Gon alves D., P. Hunziker(2016), "Transmission-blocking strategies: the roadmap from laboratory bench to the community," Malar J. 15(1), 95.
  • Geerligs P. D., B. J. Brabin, T. A. Eggelte(2003), "Analysis of the effects of malaria chemoprophylaxis in children on haematological responses, morbidity and mortality," Bull World Health Organ. 81(3), 205-216.
  • Garner P., A. M. G lmezoglu(2006), "Drugs for preventing malaria in pregnant women," Cochrane Database Syst Rev. 18(4), CD000169.
  • Fritz, R. F., J. M. Andrews(1952), "Imported and indigenous malaria in the United States," Am J Trop Med Hyg, 2, 445–56.
  • Foundation for Innovative New Diagnostics(2013), Malaria Rapid Diagnostic Tests:An Implementation guide. Geneva, FIND.
  • Endo A., H. Nishiura(2015), "Transmission dynamics of vivax malaria in the republic of Korea: Effectiveness of anti-malarial mass chemoprophylaxis," J Theor Biol, 380, 499-505.
  • Emilia V., G. W. Richard(2010), An introduction to infectious disease modelling, New York, Oxford University Press.
  • Drake T. L., S. S. Kyaw, M. P. Kyaw, F. M. Smithuis, N. P. Day, L. J. White, Y. Lubell(2015), “Cost effectiveness and resource allocation of Plasmodium falciparum malaria control in Myanmar: a modelling analysis of bed nets and community health workers,” Malar J. 14, 376.
  • Dietz K., L. Molineaux, A. Thomas(1974), “A malaria model tested in the African savannah,” Bull World Health Organ. 50(3-4), 347-357.
  • Diekmann O., J. A. P. Heesterbeek, M. G. Roberts(2010), "The construction of next generation matrices for compartmental epidemic models," J R Soc Interface. 7(47), 873-885.
  • Chotivanich K., R. Udomsangpetch, R. Suwanarusk, S. Pukrittayakamee, P. Wilairatana, J. G. Beeson, N. P. Day, N. J. White(2012), “Plasmodium vivax adherence to placental glycosaminoglycans,” PLoS One. 7(4), e34509.
  • Chang K. S., D. H. Yoo, Y. R. Ju, W. G. Lee, J. Y. Roh, H. C. Kim, T. A. Klein, E. H. Shin(2016), "Distribution of malaria vectors and incidence of vivax malaria at Korean army installations near the demilitarized zone, Republic of Korea," Malar J. 15(1), 259.
  • Carrara V. I., S. Sirilak, J. Thonglairuam, C. Rojanawatsirivet, S. Proux , V. Gilbos, A. Brockman, E. A. Ashley, R. McGready, S. Krudsood, S. Leemingsawat, S. Looareesuwan, P. Singhasivanon, N. White, F. Nosten(2006), "Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative," PLoS Med. 3(6), e183.
  • Anstey N. M., T. Handojo, M. C. Pain, E. Kenangalem, E. Tjitra, R. N. Price, G. P. Maguire(2007), "Lung injury in vivax malaria: pathophysiological evidence for pulmonary vascular sequestration and posttreatment alveolar-capillary inflammation," J Infect Dis. 195(4), 589-596.